Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab
This study has been terminated.
(Low enrollment)
Sponsor:
Nevada Cancer Institute
Collaborators:
GlaxoSmithKline
Cephalon
Information provided by:
Nevada Cancer Institute
ClinicalTrials.gov Identifier:
NCT01125787
First received: May 14, 2010
Last updated: July 19, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2011 |
| Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |